Anxiety Clinical Trials in Miami, FL

18 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
GATE-251 or Placebo for the Reduction of Symptoms of Major Depressive Disorder With Comorbid Anxiety and Insomnia	Phase 2	Syndeio Biosciences, Inc	<1 mi
Mental Health in Primary Care	N/A	University of Miami	<1 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
Improving Minority Health Through Biofeedback and Stress Reduction	N/A	Amelia Saul, PhD, CTRS, BCB	<1 mi
Cultural Adaptation of a SSI for Youth Anxiety	N/A	University of Miami	<1 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder	Phase 3	Vanda Pharmaceuticals	<1 mi
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors	Phase 4	Memorial Sloan Kettering Cancer Center	<1 mi
Radiotherapy Patient Education With Virtual Reality	N/A	University of Miami	<1 mi
Clinical Trial on Agitation in Alzheimer's Dementia	Phase 2	IGC Pharma, LLC	<1 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder	Phase 2	AbbVie	<1 mi
Community Park-Based Programs for Health Promotion: The Fit2Lead Prospective Cohort Study	—	Duke University	<1 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder	Phase 2	Intra-Cellular Therapies, Inc.	<1 mi
Community Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study	—	Duke University	<1 mi
Unified Protocol: Community Connections	N/A	University of Miami	6 mi
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age	—	State University of New York at Buffalo	17 mi
The Student Wellness and Emotional Growth Resiliency (SWAG-R) Program	N/A	Nova Southeastern University	25 mi
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)	Phase 3	Definium Therapeutics US, Inc.	26 mi
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety	Phase 3	Otsuka Pharmaceutical Development & Commercialization, Inc.	31 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.